Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Finds 4,300 Genes, Signs Expression Database Deal with UCB

Premium

GAITHERSBURG, Md.--Gene Logic said last week that with its Reads technology it has identified 2,513 genes associated with heart failure, renal disease, infertility, and other disorders, and 1,794 genes associated with mammalian toxicity. The 4,307 genes hold value as targets for new drugs or crop protection products or as markers to predict toxic effects of new compounds, the company claimed.

Earlier this month, UCB Research, a division of UCB Pharma, signed an agreement with Gene Logic for the development of a custom gene expression database for the discovery of new drugs for asthma and allergies. The companies will also collaborate to evaluate potential therapeutic targets resulting from the cooperation. Gene Logic will use its Reads technology and Affymetrix's GeneChip probe arrays to identify genes that are more or less active, or differentially expressed, in people with asthma and allergies than in healthy individuals.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.